Aspiration Biopsy in the Diagnosis of Prostatic Carcinoma: the Importance of Cytological Malignancy Grading in Prognostic Judgement and Choice of Therapy

  • P. L. Esposti

Abstract

Transrectal aspiration biopsy of the prostate, introduced by Franzèn et al. [1] at Radiumhemmet in the late 1950s has been accepted as a fast, safe and accurate procedure. At Karolinska Hospital this procedure has become routine in the last 25 years in the diagnosis of prostatic carcinoma [2].

Keywords

Adenocarcinoma Syringe 

References

  1. 1.
    Franzèn S, Giertz G, Zajicek J (1960) Cytological diagnosis of prostatic tumours by transrectal aspiration biopsy: a preliminary report. Br J Urol 32:193–196PubMedCrossRefGoogle Scholar
  2. 2.
    Esposti PL (1966) Cytologic diagnosis of prostatic tumours with the aid of transrectal aspiration biopsy. A critical review of 1,110 cases and a report of morphologic and cytochemical studies. Acta Cytol (Baltimore) 10:182–186Google Scholar
  3. 3.
    Esposti PL (1971) Cytologic malignancy grading of prostatic carcinoma by transrectal aspiration biopsy. Scand J Urol Nephrol 5:199–209PubMedCrossRefGoogle Scholar
  4. 4.
    Mostofi FK (1969) Carcinoma of the prostate. In: Riches E (ed) Modern trends in urology. Butterworth, London, pp231–263Google Scholar
  5. 5.
    Zetterberg A, Esposti PL (1980) Prognostic significance of nuclear DNA levels in prostatic carcinoma. Scand J Urol Nephrol [Suppl] 55:53–58Google Scholar
  6. 6.
    Tribukait B, Esposti PL, Rönström L (1980) Tumour ploidy for characterization of prostatic carcinoma: flow cyto-fluorometric DNA studies using aspiration biopsy material. Scand J Urol Nephrol [Suppl] 55:59–64Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1988

Authors and Affiliations

  • P. L. Esposti

There are no affiliations available

Personalised recommendations